Induction of maternal tolerance to fetal alloantigens by RANTES production

American Journal of Reproductive Immunology

Volumn 56, Issue 5-6, 2006, Pages 302-311

  Ramhorst, Rosanna ^a   Patel, Rahdika ^b   Corigliano, Adriana ^a   Etchepareborda, Juan José ^a   Fainboim, Leonardo ^a   Schust, Danny ^a,b,c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c University of Missouri   (United States)

Author keywords

Maternal tolerance; Progesterone; RANTES; Recurrent pregnancy loss

Indexed keywords

ALLOANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; FETAL ANTIGEN; MESSENGER RNA; PROGESTERONE; RANTES; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR T BET;

ALLOIMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; NIDATION; PERIPHERAL LYMPHOCYTE; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECURRENT ABORTION; T LYMPHOCYTE; TH1 CELL;

ABORTION, HABITUAL; BIOLOGICAL MARKERS; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FERTILITY; FETUS; HUMANS; IMMUNE TOLERANCE; ISOANTIGENS; MOTHERS; PROGESTERONE; RANTES; TH1 CELLS; TH2 CELLS;

EID: 33750543572     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00430.x     Document Type: Article

References (32)

1. Balkwill F: The molecular and cellular biology of the chemokines. J Viral Hepat 1998; 5: 1-14.
2. Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217-242.
3. Stephen G, Ward K, BaconMGK: Chemokines and T lymphocytes: more than an attraction. Immunity 1998; 9: 1-11.
4. Lutther AJ, Cyster JA: Chemokines as regulators of T-cell differentiation. Nat Med 2001; 2: 102-107.
5. Moser B, Loetscher P: Lymphocyte traffic control by chemokines. Nat Med 2001; 2: 123-128.
6. Faunce DE, Sonada KH, Stein-Streilen J: MIP-2 recruit NKT cells to the spleen during tolerance induction. J Immunol 2001; 166: 313-321.
7. Cui J, Shin T, Kawano H, Sato E, Kondo L, Toura Y, Kaneko H, Koseki M, Taniguchi M: Requirement for Valpha 14 NKT cells in IL-12 mediated rejection of tumors. Science 1997; 278: 1623-1626.
8. + T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002; 169: 31-38.
9. Ramhorst R, García V, Corigliano A, Rabinovich G, Fainboim L: Identification of RANTES as a novel immunomodulator of the maternal allogeneic response. Clin Immunol 2004; 1: 71-80.
10. Raghupathy R: Th1 type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18: 478-482.
11. Thellin O, Coumans B, Zorzi W, Igout A, Heinen E: Tolerance to the foeto-placental "graft": Ten ways to support a child for nine months. Curr Opin Immunol 2000; 12: 731-737.
12. Chauat G, Zourbas S, Ostoij S, Lappree-Delage G, Dubanchet S, Ledee N, Matral J: A brief review of recent data on some cytokine expressions at the materno-fetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53: 241-253.
13. Beagley KW, Gockel CM: Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003; 38: 13-22.
14. Verthelyi D: Sex hormones as immunomodulators in health and disease. Int Immunopharmacol 2001; 1: 983-993.
15. Gillgrass AE, Ashkar AA, Rosenthal KL, Kaushic C: Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J Virol 2003; 77: 9845-9851.
16. Kawana K, Kawana Y, Schust DJ: Female steroind hormones utilize Stat protein-mediated pathways to modulate the expression of T-bet in epithelial cells: A mechanism for local immune regulation in the human reproductive tract. Mol Endocrinol 2005; 19: 2047-2059.
17. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM, Kung AL, Cereb N, Yao TP, Yang SY, Reiner SL: Role of T-bet in commitment of Th1 cells before IL-12-dependent selection. Science 2001; 292: 1907-1910.
18. Miyaura H, Iwata M: Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids. J Immunol 2002; 168: 1087-1094.
19. Zhao XJ, McKerr G, Dong Z, Higgins CA, Carson J, Yang ZQ, Hannigan M: Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax 2001; 56: 205-211.
20. 2+ signaling and gene expression in T lymphocytes. J Exp Med 1998; 188: 1593-1602.
21. Yao MW, Lim H, Schust DJ, Choe SE, Farago A, Ding Y, Michaud S, Church GM, Maas RL: Gene expression profiling reveals progesterone-mediated cell cycle and immunoregulatory roles of hoxa-10 in the preimplantation uterus. Mol Endocrinol 2003; 17: 610-627.
22. Griffith TS: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
23. + T regulatory cells following antigen inoculation in an immune-privileged site. J Immunol 2003; 171: 1266-1271.
24. Tseng JF, Ryan IP, Milam TD, Murai JT, Scheriok ED, Landers DV, Taylor RN: Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1993; 81: 1118-1122.
25. Schall TJ: Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3: 165-183.
26. Caballero-Campo P, Dominguez F, Coloma J, Meseguer M, Remohi J, Pellicer A, Simón C: Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol Hum Reprod 2002; 8: 375-384.
27. Hornung D, Ryan IP, Chao VA, Vigne JL, Shecriock ED, Taylor RN: Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab 1997; 82: 1621-1628.
28. Hornung D, Klingel K, Dohrn K, Kandolf R, Wallwiener D, Tayler RN: Regulated on activation, normal T-cell expressed and -secreted mRNA expression in normal endometrium and endometriotic implants: Assessment of autocrine/paracrine regulation by in situ hybridization. Am J Pathol 2001; 158: 1949-1954.
29. Khorram O, Taylor RN, Rayan IP, Schall TJ, Landers DV: Peritoneal fluid concentration of cytokine RANTES correlate with severity of endometriosis. Am J Obstet Gynecol 1993; 169: 1545-1549.
30. Harrison RF, Barry-Kinsella C: Efficacy of medroxyprogesterone treatment in infertile women with endomtriosis: A prospective, randomized, placebo-controlled study. Fertil Steril 2000; 74: 24-30.
31. Vaercellini P, Cortesi I, Crosignanani PG: Progestins for symptomatic endometriosis: A critical analysis of evidence. Fertil Steril 1997; 68: 393-401.
32. Rugeles MT, Shearer GM: AlloDntigen recognition in utero: dual advantage for the fetus? Trends Immunol 2004; 7: 348-352.